The company is further pleased to advise shareholders that there is "No toxic funding" and "No reverse stock split" planned in the foreseeable future.
Additionally the company feels that, with this "new acquisition the company is severely under-valued relative to our revenues and our price per earnings". Based on these new figures, we feel SREH would be properly valued at substantially higher than its current market price.
SREH sister stock who got some of their filings already screaming today up 200% already. SREH next on watch. Bill said filings and news releases are coming on both.